Pediatric exclusivity bill markup
Executive Summary
Legislation on reauthorizing the pediatric exclusivity provisions is scheduled to be marked up by the House Commerce/Health Subcommittee Sept. 13. Full committee markup is planned for Sept. 20. Rep. Greenwood (R-Pa.) is sponsoring the legislation, with Rep. Eshoo (D-Calif.) as cosponsor. Rep. Waxman (D-Calif.), who cosponsored the original pediatric exclusivity legislation with Greenwood, declined to cosponsor the reauthorization bill and will offer amendments during markup (1"The Pink Sheet" July 23, p. 7)
You may also be interested in...
Pediatric Drug Exclusivity Reauthorization Expected In House Before August
Legislation reauthorizing pediatric exclusivity for drugs is expected to be introduced in the House by Rep. Greenwood (R-Penn.) before Congress' August recess.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials